Emerging cell therapy for biliary diseases.
作者信息
Kurial Simone N T, Willenbring Holger
机构信息
Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California San Francisco, San Francisco, CA, USA.
Department of Surgery, Division of Transplant Surgery, University of California San Francisco, San Francisco, CA, USA.
出版信息
Science. 2021 Feb 19;371(6531):786-787. doi: 10.1126/science.abg3179.
Abstract
摘要
相似文献
1
Emerging cell therapy for biliary diseases.新兴的胆道疾病细胞疗法。
Science. 2021 Feb 19;371(6531):786-787. doi: 10.1126/science.abg3179.
2
Cholangiocyte organoids can repair bile ducts after transplantation in the human liver.胆管细胞类器官可在人肝移植后修复胆管。
Science. 2021 Feb 19;371(6531):839-846. doi: 10.1126/science.aaz6964.
3
Liver ductal organoids reconstruct intrahepatic biliary trees in decellularized liver grafts.肝导管类器官在去细胞化肝移植物中重建肝内胆管树。
Biomaterials. 2022 Aug;287:121614. doi: 10.1016/j.biomaterials.2022.121614. Epub 2022 Jun 1.
4
Biliary Atresia - emerging diagnostic and therapy opportunities.先天性胆道闭锁——新的诊断和治疗机会。
EBioMedicine. 2021 Dec;74:103689. doi: 10.1016/j.ebiom.2021.103689. Epub 2021 Nov 12.
5
A novel model of injured liver ductal organoids to investigate cholangiocyte apoptosis with relevance to biliary atresia.一种新的损伤胆管类器官模型，用于研究与胆道闭锁相关的胆管细胞凋亡。
Pediatr Surg Int. 2020 Dec;36(12):1471-1479. doi: 10.1007/s00383-020-04765-2. Epub 2020 Oct 21.
6
Biliary organoids uncover delayed epithelial development and barrier function in biliary atresia.胆道类器官揭示了胆道闭锁中上皮发育和屏障功能的延迟。
Hepatology. 2022 Jan;75(1):89-103. doi: 10.1002/hep.32107. Epub 2021 Dec 4.
7
Cholangiocyte organoids as a cell source for biliary repair.胆管上皮细胞类器官作为胆管修复的细胞来源。
Transpl Int. 2021 Jun;34(6):999-1001. doi: 10.1111/tri.13902. Epub 2021 Jun 10.
8
Scaffolds obtained from decellularized human extrahepatic bile ducts support organoids to establish functional biliary tissue in a dish.脱细胞化的人肝外胆管支架在体外支持类器官建立功能性胆管组织。
Biotechnol Bioeng. 2021 Feb;118(2):836-851. doi: 10.1002/bit.27613. Epub 2020 Nov 9.
9
Regional Differences in Human Biliary Tissues and Corresponding In Vitro-Derived Organoids.人类胆道组织的区域性差异及其相应的体外衍生类器官。
Hepatology. 2021 Jan;73(1):247-267. doi: 10.1002/hep.31252.
10
Shaping Tomorrow's Liver Organoids: A Journey Toward Integrating Bile Ducts.塑造明日的肝脏类器官：通向整合胆管的征程。
Adv Biol (Weinh). 2024 Feb;8(2):e2300450. doi: 10.1002/adbi.202300450. Epub 2023 Oct 16.
引用本文的文献
1
Advanced therapies for congenital biliary tract malformation: From bench to bedside.先天性胆道畸形的先进疗法：从实验台到病床边
ILIVER. 2022 Aug 30;1(3):159-168. doi: 10.1016/j.iliver.2022.08.003. eCollection 2022 Sep.
2
Modularized microrobot with lock-and-detachable modules for targeted cell delivery in bile duct.具有锁定和可拆卸模块的模块化微机器人，用于胆管中靶向细胞递药。
Sci Adv. 2023 Dec 15;9(50):eadj0883. doi: 10.1126/sciadv.adj0883.
3
Human biliary epithelial cells from discarded donor livers rescue bile duct structure and function in a mouse model of biliary disease.废弃供体肝脏中的人胆管上皮细胞可挽救胆道疾病小鼠模型中的胆管结构和功能。
Cell Stem Cell. 2022 Mar 3;29(3):355-371.e10. doi: 10.1016/j.stem.2022.02.006.
本文引用的文献
1
Tissue-Engineered Bile Ducts for Disease Modeling and Therapy.用于疾病建模与治疗的组织工程胆管
Tissue Eng Part C Methods. 2021 Feb;27(2):59-76. doi: 10.1089/ten.TEC.2020.0283. Epub 2021 Feb 2.
2
Direct reprogramming of human umbilical vein- and peripheral blood-derived endothelial cells into hepatic progenitor cells.将人脐静脉和外周血来源的内皮细胞直接重编程为肝祖细胞。
Nat Commun. 2020 Oct 21;11(1):5292. doi: 10.1038/s41467-020-19041-z.
3
Clinical application of hepatocyte transplantation: current status, applicability, limitations, and future outlook.肝细胞移植的临床应用：现状、适用性、局限性和未来展望。
Expert Rev Gastroenterol Hepatol. 2020 Mar;14(3):185-196. doi: 10.1080/17474124.2020.1733975. Epub 2020 Mar 2.
4
Biliary Obstruction Promotes Multilineage Differentiation of Hepatic Stem Cells.胆管梗阻促进肝干细胞的多谱系分化。
Hepatol Commun. 2019 May 23;3(8):1137-1150. doi: 10.1002/hep4.1367. eCollection 2019 Aug.
5
Cholangiocyte pathobiology.胆管细胞病理生物学。
Nat Rev Gastroenterol Hepatol. 2019 May;16(5):269-281. doi: 10.1038/s41575-019-0125-y.
6
Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients.诱导多能干细胞的低免疫原性衍生物可逃避完全免疫活性同种异体受者的免疫排斥。
Nat Biotechnol. 2019 Mar;37(3):252-258. doi: 10.1038/s41587-019-0016-3. Epub 2019 Feb 18.
7
De novo formation of the biliary system by TGFβ-mediated hepatocyte transdifferentiation.TGFβ 介导体肝细胞转分化形成新的胆道系统。
Nature. 2018 May;557(7704):247-251. doi: 10.1038/s41586-018-0075-5. Epub 2018 May 2.
8
Conversion of Terminally Committed Hepatocytes to Culturable Bipotent Progenitor Cells with Regenerative Capacity.终末分化的肝细胞向具有再生能力的可培养双能祖细胞的转化。
Cell Stem Cell. 2017 Jan 5;20(1):41-55. doi: 10.1016/j.stem.2016.10.007. Epub 2016 Nov 10.
9
Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes.人诱导多能干细胞来源胆管细胞的发育与特性研究
Lab Invest. 2015 Jun;95(6):684-96. doi: 10.1038/labinvest.2015.51. Epub 2015 Apr 13.
10
Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes.双潜能成年肝脏祖细胞源自长期受损的成熟肝细胞。
Cell Stem Cell. 2014 Nov 6;15(5):605-18. doi: 10.1016/j.stem.2014.09.008. Epub 2014 Oct 9.
Zotero 插件